Latest Articles

Publication Date
Proteomics secures Australian patent for endometriosis test - SMH.com.au

Proteomics secures Australian patent for endometriosis test SMH.com.au

Published: Aug. 13, 2026, 5:04 a.m.
Proteomics International Laboratories Secures Australian Patent Acceptance for PromarkerEndo - smallcaps.com.au

Proteomics International Laboratories Secures Australian Patent Acceptance for PromarkerEndo smallcaps.com.au

Published: Aug. 13, 2026, 4:16 a.m.
Proteomics International’s (ASX:PIQ) Endometriosis Test Moves Forward With New Patent Development - Kalkine

Proteomics International’s (ASX:PIQ) Endometriosis Test Moves Forward With New Patent Development Kalkine

Published: Aug. 13, 2026, 1:32 a.m.
Proteomics International’s (ASX:PIQ) Endometriosis Test Moves Forward With New Patent Development - kalkine.com.au

Proteomics International’s (ASX:PIQ) Endometriosis Test Moves Forward With New Patent Development kalkine.com.au

Published: Aug. 13, 2026, 1:32 a.m.
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test - kalkine.com.au

Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test kalkine.com.au

Published: Aug. 12, 2026, 11:15 p.m.
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test - Kalkine

Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test Kalkine

Published: Aug. 12, 2026, 11:15 p.m.
Multi-omics profiling identifies an immunometabolic signature associated with endometriosis.

Endometriosis (EM) is a chronic inflammatory gynaecological disorder affecting approximately 10% of women of reproductive age. Early diagnosis remains challenging because definitive diagnosis still relies on invasive surgical confirmation. This …

Published: Aug. 11, 2026, midnight
EGF as a non-invasive biomarker of endometriosis: a case control study.

Endometriosis is a chronic inflammatory condition that affects an estimated 1 in 10 women but is often mis- and underdiagnosed due to its non-specific symptoms and the lack of a …

Published: July 29, 2026, midnight
Proteomics taps Healius network for national diagnostics rollout - SMH.com.au

Proteomics taps Healius network for national diagnostics rollout SMH.com.au

Published: July 22, 2026, 6:30 a.m.
Integrative serum proteomic and metabolomic profiling in ovarian endometrioma: an exploratory multi-omics study.

Ovarian endometrioma (OEM) is a common manifestation of endometriosis and is associated with both local lesions and systemic alterations. While immune dysregulation and metabolic disturbances have been individually reported in …

Published: July 22, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!